BioSpace News Archive

Biotech Beach

Neuralace Medical Announces First Patients Enrolled in the AT-PDN Study Evaluating Axon Therapy® for the Treatment of Painful Diabetic Neuropathy

Neuralace Medical, Inc., a commercial-stage medical technology company focused on innovative, non-invasive solutions for treatment of chronic neuropathic pain, is announcing the commencement and first patients enrolled in the Axon Therapy and Painful Diabetic Neuropathy (AT-PDN) study.

January 9, 2023
·
2 min read
Business

Foundation Medicine and Natera Announce the Launch of FoundationOne®Tracker Personalized Circulating Tumor DNA Monitoring Assay for Investigational Use and Early Access Clinical Use

Foundation Medicine, Inc. today launched an early access program for clinical use of FoundationOne®Tracker, a personalized circulating tumor DNA (ctDNA) monitoring assay.

January 9, 2023
·
7 min read
Business

CureVac Appoints Alexander Zehnder as CEO From April 1, 2023

CureVac N.V. today announced that after more than 10 years as a member of the CureVac management board and three years as CEO, Dr. Franz Haas will step down as CEO, effective March 31, 2023. Dr. Alexander Zehnder will succeed Dr. Haas, joining from Sanofi on April 1, 2023.

January 9, 2023
·
7 min read
Theravance Biopharma, Inc. Highlights 2022 Accomplishments and 2023 Key Targets

Theravance Biopharma, Inc. announced its 2022 Accomplishments and 2023 Key Targets.

January 9, 2023
·
8 min read
Business

Ironwood Pharmaceuticals Provides Update on FY 2022 Financial Guidance and Announces FY 2023 Financial Guidance

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today provided updated financial guidance for full year 2022 and announced financial guidance for full year 2023.

January 9, 2023
·
14 min read
REGENATIVE LABS PUBLISHES CASE STUDY DEMONSTRATING NEW APPLICATION OF WHARTON’S JELLY ALLOGRAFTS IN POST-SURGICAL BREAST REDUCTION CARE

Regenative Labs (Regenative), a leading HCT/P manufacturer has published a case study in the Journal of Biomedical Research and Environmental Sciences alongside Dr. Alan Meglin, of Advanced Regenerative Therapy in Georgia.

January 9, 2023
·
4 min read
Biotech Bay

IDEAYA Announces IND Clearance by U.S. FDA enabling Phase 1 Initiation for First-in-Class PARG Development Candidate IDE161

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) announced that the U.S. Food and Drug Administration (FDA) has completed its safety review of the Investigational New Drug (IND) application and concluded that IDEAYA’s proposed clinical study may proceed to evaluate IDE161 in solid tumors.

January 9, 2023
·
4 min read
Bio NC

Grail Introduces State-of-the-Art Methylation-Based Solution to Accelerate Cancer Research in the Post-Diagnosis Setting

GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, announced the availability of a state-of-the-art research use only offering for biopharmaceutical companies.

January 9, 2023
·
3 min read
Business

ADARx Pharmaceuticals Expands Leadership Team, Appointing Robert MacLeod, Ph.D. as Chief Scientific Officer

ADARx Pharmaceuticals, Inc., a clinical stage biotechnology company developing RNA-targeting therapeutics, announced the expansion of their leadership team through the appointment of Robert MacLeod, Ph.D. as Chief Scientific Officer.

January 9, 2023
·
2 min read
BioMidwest

KemPharm Announces Board and Leadership Changes to Support its Transformation into a Leading Rare Disease Company

KemPharm, Inc. announced changes to its Board of Directors and executive leadership team as part of the Company’s ongoing business transformation initiatives.

January 9, 2023
·
9 min read